Tarsons Products
IPO Size
`1023.47 Cr
Price Band
`635-662 Per Share
Minimum Lot Size
22 Share
Face Value
`2 Per Share
Employee Discount
NA
Retail Allocation
35
Issue Open Date
15 Nov,2021
Issue Close Date
17 Nov,2021
Listing Date
IPO Size
Price Band
Minimum Lot Size
Face Value
Employee Discount
Retail Allocation
Issue Open Date
Issue Close Date
Listing Date
Tarson Products Limited is an Indian labware company engaged in the designing, development, manufacturing, and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies and hospitals.
As of June 30, 2021 company has a diversified product portfolio with over 1,700 SKUs across 300 products. Our product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes, and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders, and tube racks. ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors, and others.
The firm currently operates through our five manufacturing facilities located in West Bengal. These facilities are vertically integrated and equipped with automated support systems that help us maintain quality, increase productivity, and reduce costs. Our key manufacturing facilities are ISO 9001:2015 and ISO 13485:2016/NS-EN ISO 13485:2016 certified.
| S.No. | 1 - Company | 2 - Directors | 3 - Promoters | |||
| Entity Name | By the Company | Against the Company | By the Director | Against the Director | By the Promoter | Against the Promoter |
| Criminal cases | - | - | - | - | - | - |
| Material civil cases | - | - | - | - | - | - |
| Taxation matters | - | - | - | - | - | - |
| Regulatory Proceedings | - | - | - | - | - | - |
| Income Statement(in Milllions) | FY21 | FY20 | FY19 |
| Gross Operating Income | 2,342.91 | 1,800.54 | 1,847.19 |
| Cost of Employee & Inventory | 244.36 | 200.89 | 161.35 |
| Other Expenses | 1,254.73 | 1,066.48 | 1,070.81 |
| EBITDA | 1,088.18 | 734.06 | 776.38 |
| Finance Cost | 27.22 | 61.03 | 72.49 |
| Depreciation | 136.62 | 141.7 | 145.64 |
| Profit Before Tax | 924.34 | 531.33 | 558.25 |
| Tax | 235.64 | 126.02 | 168.67 |
| Profit After Tax | 688.70 | 405.31 | 389.58 |
SANJIVE SEHGAL AND ROHAN SEHGAL
No listed peer company
The company will not receive any proceeds from the Offer for Sale worth Rs 873.47cr.
Net proceeds from the fresh issue worth Rs 150 cr will be utilized for:-• Repayment/prepayment of all or certain of our borrowings; • Funding a part of the capital expenditure for the new manufacturing facility at Panchla, West Bengal (the “Proposed Expansion”); • General corporate purposes.